MEDAGLINI DONATA

Donata
Medaglini
Professore Ordinario

Contacts

0577232485 [int.2485]

Curriculum Vitae

Teaching activities

Completion accademic year: 2026/2027

Course year: 2 First cycle degree (DM 270) BIOTECHNOLOGIES A.Y. 2025/2026
Course year: 3 Full cicle (6 years) DENTISTRY AND DENTAL PROSTHODONTICS A.Y. 2024/2025
Course year: 2 Second cycle degree (Laurea Magistrale) MEDICAL BIOTECHNOLOGIES A.Y. 2025/2026

Completion accademic year: 2025/2026

Course year: 3 Full cicle (6 years) DENTISTRY AND DENTAL PROSTHODONTICS A.Y. 2023/2024
Course year: 2 First cycle degree (DM 270) BIOTECNOLOGIE A.Y. 2024/2025
Course year: 2 Second cycle degree (Laurea Magistrale) MEDICAL BIOTECHNOLOGIES A.Y. 2024/2025

Research

Ultime pubblicazioni:

  • Martinez-Murillo, P., Alvarez, C., Santoro, F., Novedrati, M., Sonnati, C., Montesi, G., et al. (2026). In vitro cellular tropism and immunomodulatory response to rVSVΔG-ZEBOV-GP in human cells derived from tissues associated with adverse events. MICROBIOLOGY SPECTRUM [10.1128/spectrum.00408-25]. - view more
  • Mamede, I., Luschër-Dias, T., Moscardini, I.F., Gonzales-Dias, P., Marinho, B., Marcon, F., et al. (2026). Long non-coding RNAs in response to Ebola virus vaccine-induced immunity. FRONTIERS IN IMMUNOLOGY, 16 [10.3389/fimmu.2025.1695514]. - view more
  • Soldateschi, L., Leoncini, S., Fiorino, F., Lucchesi, S., Polvere, J., Boasiako, L., et al. (2026). Unexpectedly competent immune response to SARS-CoV-2 vaccination in Rett syndrome. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 22(1) [10.1080/21645515.2026.2612817]. - view more
  • Henriquez, T., Santoro, F., Medaglini, D., Pallecchi, L., Paccagnini, E., Gentile, M., et al. (2025). Establishment and application of a vesicle extraction method for clinical strains of Pseudomonas aeruginosa [10.1101/2025.11.17.688223]. - view more
  • Hanumunthadu, B., Demissie, T., Greenland, M., Skidmore, P., Tanha, K., Crocker-Buque, T., et al. (2025). Safety and immunogenicity of the invasive non-typhoidal Salmonella (iNTS)-GMMA vaccine: a first-in-human, randomised, dose escalation trial. EBIOMEDICINE, 119 [10.1016/j.ebiom.2025.105903]. - view more